Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies
暂无分享,去创建一个
[1] H. Schulz,et al. Role of oxidative stress in ultrafine particle-induced exacerbation of allergic lung inflammation. , 2009, American journal of respiratory and critical care medicine.
[2] J. Crapo,et al. Allometric relationships of cell numbers and size in the mammalian lung. , 1992, American journal of respiratory cell and molecular biology.
[3] C. Pope,et al. Health effects of particulate air pollution: time for reassessment? , 1995, Environmental health perspectives.
[4] W. Busse,et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. , 2008, American journal of respiratory and critical care medicine.
[5] H. Schulz,et al. Dosimetry and toxicology of inhaled ultrafine particles , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[6] W. Busse,et al. Allergy and asthma , 1999, Nature.
[7] Charles N. Serhan,et al. Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.
[8] P. Helms,et al. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[9] B. Levy,et al. Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury1 , 2005, The Journal of Immunology.
[10] O. Raaschou-Nielsen,et al. Size distribution and total number concentration of ultrafine and accumulation mode particles and hospital admissions in children and the elderly in Copenhagen, Denmark , 2007, Occupational and Environmental Medicine.
[11] L. Akinbami,et al. National surveillance for asthma--United States, 1980-2004. , 2007, Morbidity and mortality weekly report. Surveillance summaries.
[12] Shinji Takenaka,et al. Generation of Ultrafine Particles by Spark Discharging , 2004 .
[13] S. Holgate,et al. Treatment strategies for allergy and asthma , 2008, Nature Reviews Immunology.
[14] W. Kreyling,et al. Ultrafine particle-lung interactions: does size matter? , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[15] P. Tiittanen,et al. Ultrafine particles in urban air and respiratory health among adult asthmatics. , 2001, The European respiratory journal.
[16] A. Peters,et al. Short-term effects of particulate air pollution on respiratory morbidity in asthmatic children. , 1997, The European respiratory journal.
[17] H. Schulz,et al. Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. , 2006, The Journal of allergy and clinical immunology.
[18] J. Heyder,et al. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. , 2005, Free radical biology & medicine.
[19] E. Karg,et al. Oxymetazoline Inhibits Proinflammatory Reactions: Effect on Arachidonic Acid-Derived Metabolites , 2006, Journal of Pharmacology and Experimental Therapeutics.
[20] A. Peters,et al. Respiratory effects are associated with the number of ultrafine particles. , 1997, American journal of respiratory and critical care medicine.
[21] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[22] L. Palmer,et al. Diminished lipoxin biosynthesis in severe asthma. , 2005, American journal of respiratory and critical care medicine.
[23] C. Serhan. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.
[24] C. Denzlinger,et al. Biology and pathophysiology of leukotrienes. , 1996, Critical reviews in oncology/hematology.
[25] W. Pierson,et al. Particulate air pollution and hospital emergency room visits for asthma in Seattle. , 1993, The American review of respiratory disease.
[26] John Savill,et al. Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.
[27] B. Levy,et al. Endogenous lipid mediators in the resolution of airway inflammation , 2007, European Respiratory Journal.
[28] J. Ring,et al. Effects of Inhaled CdO Particles on the Sphingolipid Synthesis of Rat Lungs , 2003, Inhalation toxicology.
[29] J. Moreau,et al. FunctionsIL-10, Which Down-Regulates Dendritic Cell Enhances the Production of Endogenous 2 Cyclooxygenase-2-Issued Prostaglandin E , 2002 .
[30] E. Israel,et al. Corticosteroid suppression of lipoxin A4 and leukotriene B4from alveolar macrophages in severe asthma , 2010, Respiratory research.
[31] Bree L van,et al. Multiple Path Particle Deposition Model (MPPDep Version 1.11). A model for human and rat airway particle deposition , 1999 .
[32] H. Schulz,et al. Effects of ultrafine particles-induced oxidative stress on Clara cells in allergic lung inflammation , 2010, Particle and Fibre Toxicology.
[33] D. Dockery,et al. Longitudinal studies of air pollution effects on lung function. , 1996, American journal of respiratory and critical care medicine.
[34] M. Schladweiler,et al. Soluble iron modulates iron oxide particle-induced inflammatory responses via prostaglandin E2 synthesis: In vitro and in vivo studies , 2009, Particle and Fibre Toxicology.
[35] B. Levy,et al. Resolvins and protectins: mediating solutions to inflammation , 2009, British journal of pharmacology.
[36] E. Chi,et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. , 2002, American journal of respiratory and critical care medicine.
[37] Choon-Sik Park,et al. Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor. , 2010, American journal of respiratory cell and molecular biology.
[38] W G Kreyling,et al. Distribution Pattern of Inhaled Ultrafine Gold Particles in the Rat Lung , 2006, Inhalation toxicology.
[39] W. Henderson,et al. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. , 2003, The Journal of allergy and clinical immunology.
[40] C. Vancheri,et al. The lung as a privileged site for the beneficial actions of PGE2. , 2004, Trends in immunology.
[41] E. Karg,et al. Oxymetazoline Inhibits and Resolves Inflammatory Reactions in Human Neutrophils , 2009, Journal of Pharmacological Sciences.
[42] J. Heyder,et al. Agglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophages. , 2001, Environmental health perspectives.
[43] Christopher D. Simpson,et al. Microstructure and oxidation behaviour of Euro IV diesel engine soot: a comparative study with synthetic model soot substances , 2004 .
[44] S. Weinbruch,et al. Transmission electron microscopical and aerosol dynamical characterization of soot aerosols , 2003 .
[45] B. Levy,et al. Lipid mediators as agonists for the resolution of acute lung inflammation and injury. , 2007, American journal of respiratory cell and molecular biology.
[46] Chang-Yu Wu,et al. Combustion Aerosols: Factors Governing Their Size and Composition and Implications to Human Health , 2000, Journal of the Air & Waste Management Association.
[47] D. Denis,et al. The Immunomodulatory Actions of Prostaglandin E2 on Allergic Airway Responses in the Rat1 , 2002, The Journal of Immunology.
[48] Takao Shimizu,et al. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. , 2009, Annual review of pharmacology and toxicology.
[49] R. Phipps,et al. Prostaglandins as modulators of immunity. , 2002, Trends in immunology.
[50] C. Brander,et al. The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. , 2006, Blood.